Octagon Capital Advisors’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-34,500
Closed -$7.76M 43
2022
Q3
$7.76M Buy
+34,500
New +$7.76M 1.34% 18